GHRP-2 (5mg / 10mg) – Growth Hormone-Releasing Peptide Research Material
GHRP-2 (5mg / 10mg), also known as Growth Hormone-Releasing Peptide-2 or pralmorelin, is a synthetic peptide belonging to the growth hormone secretagogue (GHS) class. It has been investigated extensively for its interaction with the growth hormone secretagogue receptor and its ability to stimulate growth hormone release in experimental and clinical research settings.
GHRP-2 is particularly relevant to research involving the growth hormone (GH) axis, ghrelin signalling, pituitary hormone secretion and appetite regulation. Unlike growth hormone itself, GHRP-2 is a secretagogue: research focuses on its ability to stimulate endogenous GH secretion through receptor-mediated pathways.
The referenced product is available in 5mg and 10mg quantities and is intended for laboratory and scientific research. It should not be presented as an approved medicine, dietary supplement or treatment for human use.
What Is GHRP-2?
GHRP-2 is a synthetic growth hormone-releasing peptide. It is also known by the name pralmorelin and has been studied as a growth hormone secretagogue. Scientific literature describes GHRP-2 as an agonist of the ghrelin receptor and a compound capable of stimulating growth hormone secretion.
GHRP-2 was developed as part of research into synthetic peptides capable of stimulating the secretion of growth hormone. Clinical and experimental investigations have subsequently examined its effects on GH secretion and related physiological pathways.
GHRP-2 (5mg / 10mg) – Product Highlights
- Product name: GHRP-2
- Alternative name: Pralmorelin
- Full name: Growth Hormone-Releasing Peptide-2
- Available quantities: 5mg and 10mg
- Product class: Growth hormone secretagogue research peptide
- Primary research focus: Growth hormone secretion and GHS receptor signalling
- Additional research areas: Ghrelin signalling, appetite regulation and pituitary endocrinology
- Intended use: Laboratory and scientific research
Researchers should consult the current supplier documentation and applicable batch-specific analytical information for exact product specifications, purity and storage requirements.
GHRP-2 and Growth Hormone Research
Growth hormone is an important peptide hormone produced primarily by the pituitary gland. Its secretion is regulated by a complex network involving growth hormone-releasing hormone, somatostatin and other signalling pathways.
GHRP-2 has been studied because it can stimulate GH secretion through the growth hormone secretagogue system. Research in people with growth hormone deficiency has demonstrated that GHRP-2 can increase circulating GH concentrations under experimental conditions.
These findings make GHRP-2 useful as a research tool for investigating the mechanisms controlling pituitary growth hormone secretion.
How GHRP-2 Relates to the Ghrelin Receptor
GHRP-2 is closely associated with the ghrelin signalling system. Scientific research describes GHRP-2 as a synthetic agonist of the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHSR).
Ghrelin is a naturally occurring peptide hormone involved in several physiological processes, including appetite regulation and stimulation of growth hormone secretion. GHRP-2 provides researchers with a synthetic compound through which this receptor system can be investigated.
This receptor relationship is one of the reasons GHRP-2 has been studied in both endocrinology and metabolic research.
GHRP-2 and Pituitary Research
The pituitary gland plays a central role in endocrine regulation, including the secretion of growth hormone.
Research has investigated whether GHRP-2 requires an intact growth hormone-releasing hormone receptor pathway to stimulate GH secretion. In a study involving people with isolated GH deficiency caused by mutations affecting the GHRH receptor, GHRP-2 still produced a measurable increase in serum GH, although the response was considerably smaller than in controls.
These findings support the use of GHRP-2 in research examining the relationship between the growth hormone secretagogue system and traditional GHRH-mediated signalling.
GHRP-2 and Growth Hormone Secretagogue Research
GHRP-2 belongs to a wider group of compounds known as growth hormone secretagogues. These substances are studied because they can stimulate the release of endogenous growth hormone rather than supplying GH directly.
This distinction is important when comparing GHRP-2 with recombinant growth hormone or other hormone-based research materials. GHRP-2 acts through receptor-mediated signalling to influence the body’s own GH secretion.
Research into growth hormone secretagogues has contributed to a broader understanding of endocrine regulation and the physiological control of GH release.
GHRP-2 and Appetite Research
Because GHRP-2 interacts with the ghrelin receptor system, researchers have also investigated its effects on appetite and food intake.
In a controlled study involving healthy men, GHRP-2 infusion increased food intake compared with saline. The researchers reported that the response resembled the appetite-stimulating effects associated with ghrelin.
A separate controlled study involving lean and obese participants found that GHRP-2 increased food intake in a dose-dependent manner and also increased serum GH concentrations.
These findings demonstrate why GHRP-2 can be useful in research examining the relationship between growth hormone secretion, ghrelin signalling and appetite.
GHRP-2 and Metabolic Research
The relationship between growth hormone secretion and appetite makes GHRP-2 relevant to metabolic research.
Experimental studies have investigated GHRP-2 in relation to food intake, hunger and hormonal responses. The observed effects are influenced by experimental conditions, including dose, administration method, participant characteristics and study duration.
Researchers can therefore use GHRP-2 as a tool for investigating interactions between the GH axis and ghrelin-related metabolic signalling.
GHRP-2 and Endocrine Research
GHRP-2 is particularly useful for experimental endocrinology because it interacts with a hormone-regulatory pathway rather than functioning simply as a replacement hormone.
Research can examine:
- Growth hormone secretion.
- Growth hormone secretagogue receptor activity.
- Ghrelin-related signalling.
- Pituitary endocrine responses.
- Interactions between GHRP and GHRH pathways.
- Appetite and food-intake signalling.
- Hormonal responses to receptor stimulation.
These applications make GHRP-2 relevant to laboratory studies involving endocrine physiology and receptor pharmacology.
GHRP-2 Research Applications
GHRP-2 may be of interest to researchers studying:
- Growth hormone secretion: Investigation of endogenous GH release.
- GHS receptor signalling: Study of growth hormone secretagogue receptor activity.
- Ghrelin biology: Investigation of ghrelin-related pathways.
- Pituitary endocrinology: Study of pituitary hormone responses.
- Metabolic research: Investigation of appetite and hormonal regulation.
- Receptor pharmacology: Evaluation of peptide-receptor interactions.
- Endocrine physiology: Study of the mechanisms controlling GH secretion.
- Analytical research: Development and validation of methods for detecting and measuring GHRP-2.
GHRP-2 and Analytical Research
GHRP-2 has also been investigated using analytical chemistry techniques. Researchers have developed methods for detecting GHRP-2 and its metabolites in biological samples.
For example, liquid chromatography combined with electrospray ionisation tandem mass spectrometry has been used to identify GHRP-2 and a related metabolite in human urine. Such analytical methods demonstrate the importance of accurate peptide identification in laboratory and sports-science research.
Analytical characterisation can be particularly valuable when researchers need to distinguish GHRP-2 from structurally related peptides or metabolites.
GHRP-2 and Sports Science
Growth hormone secretagogues have attracted attention in sports science because of their effects on the GH axis. GHRP-2 has therefore been investigated in the context of anti-doping analysis.
Published analytical research notes that GHRP-2 is prohibited for use by athletes under anti-doping rules and describes methods for identifying the peptide and its metabolite in urine.
Researchers working in sports science should therefore take relevant anti-doping regulations into account when designing studies involving GHRP-2.
GHRP-2 vs GHRP-6
GHRP-2 and GHRP-6 belong to the same broad family of growth hormone-releasing peptides, but they are different compounds.
| Characteristic | GHRP-2 | GHRP-6 |
|---|---|---|
| Full name | Growth Hormone-Releasing Peptide-2 | Growth Hormone-Releasing Peptide-6 |
| Alternative name | Pralmorelin | GHRP-6 |
| Research class | Growth hormone secretagogue | Growth hormone secretagogue |
| Research focus | GH secretion and ghrelin/GHS receptor signalling | GH secretion and related secretagogue signalling |
Researchers should use the exact peptide identified in the study protocol because closely related secretagogues may produce different receptor and physiological responses.
GHRP-2 and GHRH: Different Signalling Systems
GHRP-2 should not be confused with growth hormone-releasing hormone (GHRH) analogues such as Mod GRF 1-29.
| Research Material | General Research Classification |
|---|---|
| GHRP-2 | Growth hormone secretagogue associated with GHSR/ghrelin signalling |
| GHRH analogues | Compounds that act through the GHRH receptor pathway |
| Growth hormone | Hormone itself rather than a secretagogue |
Understanding these distinctions is important when interpreting endocrine research and comparing different peptide research materials.
GHRP-2 Product Quantities
The referenced GHRP-2 product is available in 5mg and 10mg quantities. The quantity refers to the amount of research material supplied and should not be interpreted as a recommended human dose.
| Option | Research Material |
|---|---|
| 5mg | GHRP-2 research peptide |
| 10mg | GHRP-2 research peptide |
GHRP-2 Product Specifications
| Specification | Details |
|---|---|
| Product name | GHRP-2 |
| Alternative name | Pralmorelin |
| Full name | Growth Hormone-Releasing Peptide-2 |
| Available quantities | 5mg / 10mg |
| Research classification | Growth hormone secretagogue |
| Primary research area | Growth hormone secretion |
| Receptor system | Growth hormone secretagogue receptor / ghrelin signalling |
| Additional research areas | Appetite, endocrine and metabolic research |
| Intended use | Laboratory and scientific research |
Why Choose GHRP-2 for Laboratory Research?
GHRP-2 has a substantial scientific research history and provides a useful model for studying growth hormone secretagogue signalling.
Its research value includes:
- A well-characterised relationship with the growth hormone secretagogue receptor.
- Extensive investigation of GH stimulation.
- Published research involving human endocrine responses.
- Established relevance to ghrelin and appetite signalling.
- Use in analytical methods for peptide detection.
- Relevance to pituitary and metabolic research.
These characteristics make GHRP-2 a useful research material for appropriately designed laboratory studies.
GHRP-2 and Scientific Literature
The scientific literature surrounding GHRP-2 includes laboratory, clinical, metabolic and analytical investigations.
Research has demonstrated that GHRP-2 can stimulate GH secretion in human subjects and that its endocrine activity can occur even when the GHRH receptor pathway is impaired.
Human studies have also investigated its effects on appetite and food intake, reflecting its connection with ghrelin receptor signalling.
Analytical studies have further established methods for identifying GHRP-2 and its metabolites, demonstrating its relevance to pharmacological and anti-doping research.
Frequently Asked Questions
What is GHRP-2?
GHRP-2 is a synthetic growth hormone-releasing peptide and growth hormone secretagogue that has been investigated extensively for its effects on GH secretion and ghrelin-related signalling.
What is another name for GHRP-2?
GHRP-2 is also known as pralmorelin. Scientific literature also uses names including KP-102 and related development codes.
What does GHRP-2 research focus on?
Research commonly focuses on growth hormone secretion, growth hormone secretagogue receptor activity, ghrelin signalling, pituitary endocrinology and appetite regulation.
Does GHRP-2 interact with the ghrelin receptor?
Yes. Scientific literature describes GHRP-2 as a synthetic agonist of the ghrelin receptor, also known as the growth hormone secretagogue receptor.
Has GHRP-2 been studied in humans?
Yes. Human studies have investigated GHRP-2’s effects on growth hormone secretion, food intake and appetite.
Is GHRP-2 the same as growth hormone?
No. GHRP-2 is a growth hormone secretagogue that stimulates signalling associated with endogenous GH secretion; it is not growth hormone itself.
Is GHRP-2 the same as GHRP-6?
No. GHRP-2 and GHRP-6 are different synthetic peptides within the broader growth hormone secretagogue class.
What quantities are available?
The referenced product is offered in 5mg and 10mg quantities.
Is GHRP-2 approved for human use?
Regulatory status depends on jurisdiction and intended application. The research material described on this page should not be presented as an approved general-purpose medicine or therapeutic product.
Can research findings about GHRP-2 be directly applied to humans?
No. Results depend on the study design, experimental model and conditions. Findings from laboratory and preclinical research should not automatically be extrapolated to human outcomes.
Research Summary
GHRP-2 (5mg / 10mg) is a synthetic growth hormone-releasing peptide, also known as pralmorelin, that has been extensively studied as a growth hormone secretagogue. Scientific research has examined its interaction with the growth hormone secretagogue receptor and its effects on pituitary GH secretion.
Human research has also investigated GHRP-2 in relation to appetite and food intake, reflecting its connection with the ghrelin receptor system. Controlled studies have reported increased food intake and serum GH responses following GHRP-2 exposure under the tested conditions.
Further research has explored GHRP-2 in pituitary endocrinology and analytical science, including methods for detecting the peptide and its metabolites in biological samples.
Overall, GHRP-2 is a well-studied research peptide for investigations involving growth hormone secretion, ghrelin/GHS receptor signalling, pituitary endocrinology, appetite regulation and peptide analytics.
Research-Use Disclaimer
GHRP-2 (5mg / 10mg) is intended for laboratory and scientific research purposes only. It is not a food product, dietary supplement or general-purpose therapeutic product.
The information provided on this page is for scientific and educational purposes and does not constitute medical advice. It should not be interpreted as evidence that GHRP-2 can diagnose, treat, cure or prevent any disease or medical condition.
Human, animal and laboratory findings should be interpreted within the specific context in which they were obtained. Experimental results cannot automatically be extrapolated to clinical outcomes.
This content does not provide instructions for human administration, dosing, injection, reconstitution for human use or self-experimentation. Researchers should follow appropriate laboratory protocols, supplier documentation, institutional requirements and all applicable laws and regulations when working with research peptides.



Reviews
There are no reviews yet.